|
ACBD5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53640000114075E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.9377999445972E-09 |
| Normal-vs-Stage2 |
1.001260E-04 |
| Normal-vs-Stage3 |
3.020300E-02 |
| Normal-vs-Stage4 |
1.180630E-03 |
| Stage1-vs-Stage2 |
7.446000E-01 |
| Stage1-vs-Stage3 |
3.361400E-01 |
| Stage1-vs-Stage4 |
7.751400E-01 |
| Stage2-vs-Stage3 |
5.290200E-01 |
| Stage2-vs-Stage4 |
9.663200E-01 |
| Stage3-vs-Stage4 |
5.956600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92919999975061E-08 |
| Normal-vs-AfricanAmerican |
7.61539999949434E-07 |
| Normal-vs-Asian |
9.012100E-02 |
| Caucasian-vs-AfricanAmerican |
6.185800E-01 |
| Caucasian-vs-Asian |
4.063600E-01 |
| AfricanAmerican-vs-Asian |
3.290400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14009999721654E-08 |
| Normal-vs-Female |
3.800800E-04 |
| Male-vs-Female |
3.123600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.53861999999672E-05 |
| Normal-vs-Extreme_Weight |
1.36250011273376E-10 |
| Normal-vs-Obese |
2.04229999999361E-05 |
| Normal-vs-Extreme_Obese |
2.262700E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.299600E-01 |
| Normal_Weight-vs-Obese |
3.450000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.489200E-01 |
| Extreme_Weight-vs-Obese |
5.897600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.947600E-01 |
| Obese-vs-Extreme_Obese |
9.322400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.198900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.07559999999551E-05 |
| Normal-vs-Age(61-80Yrs) |
3.41770001188735E-09 |
| Normal-vs-Age(81-100Yrs) |
9.19230000007154E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.598000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.319600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.020500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.561860E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.141900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.637600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.2435999997027E-08 |
| Normal-VS-Type2 PRCC |
4.44320000000387E-05 |
| Normal-VS-KIRP CIMP |
1.421950E-04 |
| Normal-VS-Unclassified PRCC |
4.158500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.830800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.689200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.106650E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.241400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.741600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.746000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.62510000000827E-05 |
| Normal-vs-N1 |
1.616370E-04 |
| Normal-vs-N2 |
6.201000E-03 |
| N0-vs-N1 |
8.415800E-01 |
| N0-vs-N2 |
6.194800E-01 |
| N1-vs-N2 |
6.410400E-01 |
|
|
